Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Cardiovascular LLC

Sep 02, 2008, 01:00 ET from Terumo Cardiovascular Systems

    ANN ARBOR, Mich., Sept. 2 /PRNewswire/ -- Terumo Cardiovascular Systems
 (Terumo CVS) announced that it filed a patent infringement complaint on
 August 21 in the Northern District of California against Maquet
 Cardiovascular LLC. The complaint alleges that Maquet's Vasoview(R)
 Endoscopic Vessel Harvesting Systems infringe a patent for which Terumo CVS
 owns the rights. The complaint also requests an injunction against further
 sales of the product in the U.S.
     (Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO )
     Terumo CVS sells the VirtuoSaph(TM) Endoscopic Vessel Harvesting System
 in the United States. The VirtuoSaph system is distributed in Japan and
 Asia by Terumo Corporation and in Europe by Terumo's European subsidiary.
     "Terumo respects the valid intellectual property of others and expects
 that its competitors will do the same," said Mark Sutter, President and
 CEO, Terumo Cardiovascular Systems.
     The VirtuoSaph system is used during coronary artery bypass grafting
 (CABG), the most common cardiac surgery procedure. During the procedure,
 the surgeon removes a healthy artery or vein from elsewhere in the body,
 most often the saphenous vein in the leg, and uses it to route blood around
 a blockage in a coronary artery. The VirtuoSaph system allows the surgical
 team to remove the saphenous vein using very small incisions. Endoscopic
 procedures have been shown to minimize scarring, morbidity and infection
 associated with traditional longitudinal incisions.
     Terumo Cardiovascular Systems Corporation is a global manufacturer and
 marketer of medical devices for cardiac and vascular surgery. The company
 is headquartered in Ann Arbor, Michigan with manufacturing operations in
 Ann Arbor; Elkton, Maryland; Ashland, Massachusetts; and Tustin,
 California. It is one of several subsidiaries of Terumo Corporation of
 Japan focused exclusively on the cardiac and vascular markets, including
 Terumo Heart Inc., developer of a ventricular assist device, and Vascutek
 Ltd, leading manufacturer of vascular grafts. For more information, visit
 www.terumo-cvs.com .
     Terumo Corporation is a premier global medical device company with
 annual sales of nearly three billion dollars for the year ending March 31,
 2008. Founded in 1921, the company develops, manufactures and distributes
 world-class medical devices for use in cardiothoracic surgery,
 interventional procedures, transfusion medicine, and needle and syringe

SOURCE Terumo Cardiovascular Systems